Semi-Annual Statement Of Income And Retained Earnings

Astellas Pharma Inc. - Filing #7332273

Concept 2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
Semi-annual statement of income and retained earnings
Statement of income and retained earnings
Operating profit (loss)
193,984,000,000 JPY
130,639,000,000 JPY
Non-operating income
Non-operating income
192,636,000,000 JPY
216,196,000,000 JPY
Non-operating expenses
Non-operating expenses
13,363,000,000 JPY
8,594,000,000 JPY
Ordinary profit (loss)
373,257,000,000 JPY
338,241,000,000 JPY
Extraordinary income
Extraordinary income
22,000,000 JPY
33,758,000,000 JPY
Extraordinary losses
Extraordinary losses
40,189,000,000 JPY
23,876,000,000 JPY
Profit (loss) before income taxes
333,090,000,000 JPY
348,123,000,000 JPY
Income taxes - current
38,435,000,000 JPY
10,719,000,000 JPY
Income taxes - deferred
2,494,000,000 JPY
23,193,000,000 JPY
Profit (loss)
JPY
JPY
JPY
292,161,000,000 JPY
JPY
292,161,000,000 JPY
JPY
292,161,000,000 JPY
JPY
JPY
JPY
JPY
292,161,000,000 JPY
JPY
JPY
JPY
314,210,000,000 JPY
314,210,000,000 JPY
JPY
JPY
JPY
314,210,000,000 JPY
JPY
314,210,000,000 JPY
JPY
JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.